Sign in
4

Changes in Ownership

BOSTON SCIENTIFIC CORP Filed Acc 0001225208-25-007716

EVP & Group Pres, Cardiology sold 50,000 shares at an average $105.43 ($5,271,416)

  • EVP & Group Pres, Cardiology acquired 50,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology 2025-09-02 Option exercise 10b5-1 +50,000 $26.15 $1,307,500 228,342 D
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology 2025-09-02 Sale 10b5-1 −21,830 $104.89 $2,289,661 206,512 D
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology 2025-09-02 Sale 10b5-1 −28,170 $105.85 $2,981,755 178,342 D
Derivatives
Fitzgerald Joseph Michael EVP & Group Pres, Cardiology 2025-09-02 Option exercise · Stock Option (Right to Buy) 10b5-1 −50,000 100,000 D
Open-market sales · 50,000 sh · avg $105.43 · $5,271,416
Loading xslF345X05/doc4.xml…